ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Stock Analyst Earnings Estimates
NASDAQ:ANPC - Nasdaq - US03635R2067 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 10.85M 5.85% | 20.51M 89.03% | 17.986M -12.31% | |
| EBITDA YoY % growth | -86.42M -113.54% | -90.03M -4.18% | -102.136M -13.45% | |
| EBIT YoY % growth | -89.08M -104.27% | -93.13M -4.55% | -106.046M -13.87% | |
| Operating Margin | -821.01% | -454.07% | -589.60% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CNY
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 6.394M 44.53% | % | ||
| Q2 2022 Q2Q % growth | 3.245M -54.11% | % | ||
| Q1 2022 Q2Q % growth | 1.968M -9.93% | % | ||
| Q4 2021 Q2Q % growth | 4.306M -73.84% | 1.948M | 2.358M | 121.05% |
| Q3 2021 Q2Q % growth | 4.424M 261.44% | 1.676M | 2.748M | 163.96% |
| Q2 2021 Q2Q % growth | 7.071M 74.55% | 1.548M | 5.523M | 356.78% |
| Q4 2020 Q2Q % growth | 16.46M 502.93% | 1.326M | 15.134M | 1,141.33% |
| Q3 2020 Q2Q % growth | -84.91% | 1.224M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |